San Antonio Breast Cancer Symposium 8 Dec, page-36

I think James Garner is a more credible source for information on data and trial stages and he’s clearly stating we are entering our operational phase and our phase 3 pivotal study and saying we are entering the rarified group of phase 3 companies.

it could all be over after 50 patients and even 20 months if we are lucky - those videos are a great watch

James set all these programs up and is responsible for the new Kazia and our success so he’s a great and credible source

think I’ll listen to and support James position over a disgruntled holder who jumped ship before a 350% increase

thanks for watching though but I learn all I need from h. @4!)